
Please try another search
Nippon Kayaku Co., Ltd. engages in mobility and imaging, fine chemicals, and life sciences businesses in Japan. The company offers airbag inflators, micro gas generators for seatbelt pretensioners and squib; and liquid crystal display (LCD) projector and display, and x-ray analysis system components. It also provides epoxy and maleimide resin, epoxy resin hardener, reactive flame retardant, acrylic acid esters, UV-curable resins for resist, resist for MEMS, cleaners for LCDs and semiconductors, and LCD sealants, as well as semiconductor manufacturing equipment, such as laminator, remover, mounter, UV irradiation equipment; colorants for inkjet printers, dyes for inkjet textile printing, inks for industrial inkjet printers, image sensor materials, dichotomous colorants for dimmable glass, near infrared absorbers, dyes for textiles and paper, colorants for resins, developers for thermal paper, and pigment derivative; and catalysts for the production of acrylic acid, acrolein, and methacrylic acid. In addition, the company offers Anti-cancer and biological drugs, cardiovascular and photodynamic diagnostic agents, in-vitro diagnostic drugs, embolization materials, pharmaceutical API and intermediates, food additives, health food ingredients, preservatives for food quality, and cleaners and disinfectants; Insecticides, herbicides, fungicides, miticides, public health insecticides, soil fumigants, and animal repellents; and engages in real estate business. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Makoto Takeda | 61 | 2022 | MD & Director |
Mitsuhiro Tsubakimoto | 66 | 2025 | Independent Outside Director |
Yasuyuki Fujishima | 78 | 2016 | Independent Outside Director |
Shigeyuki Kawamura | 62 | 2021 | President & Director |
Seiichi Fusamura | 78 | 2020 | Independent Outside Director |
Yoichiro Wada | 63 | 2023 | Full-Time Audit & Supervisory Board Member |
Hiroshi Shimada | 60 | 2023 | Senior MD, Head of Pharmaceuticals Group & Director |
Ikuko Akamatsu | 57 | 2023 | Outside Independent Director |
Shinji Inoue | 59 | 2023 | MD & Director |
Ichiro Wakasa | 70 | 2022 | Outside Audit & Supervisory Board Member |
Kyoichi Toriyama | 67 | 2024 | Outside Audit & Supervisory Board Member |
Nagafumi Saito | 60 | 2025 | Standing Audit & Supervisory Board Member |
Atsushi Iwasaki | 66 | 2024 | Outside Audit & Supervisory Board Member |
Yasuhito Kato | - | 2025 | MD & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review